Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

Entrada Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
9.83 -74.6 -4.84 -10.68
PEG Ratio
-0.01 0.80 -0.07 -0.12
PS Ratio
3.06 3.87 n/a n/a
PB Ratio
1.50 2.06 1.99 1.79
P/FCF Ratio
-14.43 3.72 -4.38 -9.64
P/OCF Ratio
-15.52 3.57 -4.51 -10.51
OCF/S Ratio
-0.2 1.08 n/a n/a
Debt / Equity Ratio
0.14 0.28 0.12 n/a
Quick Ratio
11.15 2.33 9.55 44.46
Current Ratio
11.15 2.33 9.55 44.46
Asset Turnover
0.40 0.27 n/a n/a
Interest Coverage
n/a n/a -36.95 n/a
Return on Equity
0.15 -0.03 -0.41 -0.17
Return on Assets
0.12 -0.01 -0.35 -0.16
Return on Invested Capital
0.09 0.01 -0.36 -0.17
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 0.23 n/a n/a
Net Profit Margin
0.31 -0.05 n/a n/a
Pretax Profit Margin
0.32 0.09 n/a n/a
Operating Profit Margin
0.22 -0.02 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.22 -0.00 n/a n/a